RYNTRAVIK

RYNTRAVIK International Trademark (WIPO) Information

Pharmaceutical and medicinal preparations and substances; vaccines.
Classification Information
Class Code: 005 - Pharmaceutical Products
Class Description: Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Goods & Services: Pharmaceutical and medicinal preparations and substances; vaccines.
Matter Recording History
Record Date 2023-08-24
Notification Date 2023-09-07
Effective Date 2023-08-09
Office Country CA
Publication/Registration Details
(1) 2023/34 Gaz on 2023-09-07
Goods & Services Limitation Details
Description
Class 05 - Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus (HPV), respiratory syncytial virus (RSV), hepatitis, herpes genitals, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely, disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout fractures, sprains, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone disorders, androgen disorders and estrogen disorders; pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders, namely acidifiers to increase levels of gastric acid to decrease stomach pH for human purposes; pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorder; pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders namely amenorrhoea, dysmenorrhoeal and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparation, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor symptoms, menopausal symptoms, endometriosis, uterine fibroids, Leiomyoma, endourological disorders and for the removal of renal calculi and the treatment of nephrolithiasis and urolithiasis, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medication; vaccines for human use.
Record Date 2022-07-20
Notification Date 2022-07-21
Effective Date 2022-07-20
Office Country MX
Publication/Registration Details
(1) 2022/29 Gaz on 2022-08-04
Record Date 2022-07-12
Notification Date 2022-07-13
Effective Date 2022-07-11
Office Country CA
Publication/Registration Details
(1) 2022/28 Gaz on 2022-07-28
Record Date 2022-02-25
Notification Date 2022-02-28
Effective Date 2022-02-24
Office Country CH
Publication/Registration Details
(1) 2022/8 Gaz on 2022-03-10
Record Date 2022-02-24
Notification Date 2022-02-25
Effective Date 2022-02-23
Office Country US
Publication/Registration Details
(1) 2022/8 Gaz on 2022-03-10
Record Date 2022-02-23
Notification Date 2022-02-24
Effective Date 2022-02-22
Office Country BR
Publication/Registration Details
(1) 2022/8 Gaz on 2022-03-10
Record Date 2022-01-21
Notification Date 2022-01-24
Effective Date 2022-01-20
Office Country JP
Publication/Registration Details
(1) 2022/3 Gaz on 2022-02-03
Record Date 2021-08-10
Notification Date 2021-08-11
Effective Date 2021-08-09
Office Country EM
Publication/Registration Details
(1) 2021/32 Gaz on 2021-08-26
Record Date 2021-07-27
Notification Date 2021-07-29
Effective Date 2021-07-27
Office Country AU
Publication/Registration Details
(1) 2021/30 Gaz on 2021-08-12
Record Date 2021-07-14
Notification Date 2021-07-16
Effective Date 2021-07-13
Office Country CN
Publication/Registration Details
(1) 2021/28 Gaz on 2021-07-29
Record Date 2021-03-05
Notification Date 2021-03-18
Effective Date 2021-01-08
Office Country GB
Publication/Registration Details
(1) 2021/9 Gaz on 2021-03-18
Designated Country Details
(1) AU under Protocol
(2) BR under Protocol
(3) CA under Protocol
(4) CH under Protocol
(5) CN under Protocol
(6) EM under Protocol
(7) JP under Protocol
(8) MX under Protocol
(9) US under Protocol
Goods & Services Limitation Details
Description
Class 05 - Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (hiv), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitals, herpes labialis, herpes simplex virus, varicella-zoster virus, epstein-barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment of viral conditions namely human immunodeficiency virus (hiv), hpv, rsv, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, epstein barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of metaboic related diseases and disorders namely, disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio- renal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone/androgen disorders and oestrogen disorders; pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders; pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorder; pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders namely amenorrhoea, dysmenorrhoeal and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparation, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, leiomyoma, endourology/stone, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely hepatitis, non-alcoholic fatty liver disease (nafld), non-alcoholic steatohepatitis (nash), liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medication; vaccines.
Class 05 - Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune systems related diseases and disorders; vaccines.
Word Mark: RYNTRAVIK
Current Status:
LIVE (Circa: 2021)
Expires on 1/8/2031
Application Number: 1581955
Filing Date: Friday, January 8, 2021
Receiving Office:
Language of the Application: English
Type Of Mark: Individual
Mark Feature: Word
Expected expiration date of the registration/renewal Wednesday, January 8, 2031
Designation(s) under the Madrid protocol by virtue of article 9sexies
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Publication:
UK00003569645 - 12/18/2020
Priority:
UK00003569645 - 12/18/2020 in GB
Last Applicant/Owner:
**********
**********
***** ****
Previous Applicant/Owner:
980 Great West Road
Brentford, Middlesex TW8 9GS
Correspondent:
*********
**********
***** ****
Trademarkia is the largest search engine for U.S., China, European Union, Canada, WIPO, and Australia Trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network! You can register your trademark in 180+ countries in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.
What You Can Do:
Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!
As seen on